Sitagliptin -- the diabetic drug opportunity is being chased by many players in the market today. Who gets into the doctor’s pen first and manages to stay for a long time is something one should wait and watch to see. Almost all therapies and the majority of the market players have shown a strong positive value and volume growth.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/BkxCdou
No comments:
Post a Comment